BYETTA is not recommended to be taken with insulin.

不推荐百泌达与胰岛素合用。

youdao

BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.

百泌达是FDA批准的治疗2型糖尿病的首个GLP - 1受体激动剂药物。

youdao

BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.

BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。

youdao

This is surprising because Bydureon is a long-acting version of an already approved drug, Byetta.

FORBES: Why FDA Communications Must Be Public

This drug will compete directly with both Byetta and Bydureon, which both contain exenatide.

FORBES: Lilly And Amylin End Their Bad Marriage

Kliff believes that Byetta could "easily capture" 10% of the market within the first year.

FORBES: Magazine Article